GPR4 and Alzheimer disease: Through the integration of transcriptomic association analysis and weighted gene co-expression network analysis, GPR4 was identified as one of the predictive biomarkers for AD, providing statistical evidence for its significant association with AD risk (Zhou et al., 2023).